Evaxion Biotech A/S (EVAX)

4.1000 -0.0400 (-0.97%) As of 01:27PM EDT. Market open.

Evaxion Biotech A/S

Dr. Neergaards Vej
5th Floor
Horsholm 2970
Denmark
45 53 53 18 50
https://www.evaxion-biotech.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 49

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Christian Kanstrup M.Sc.	Chief Executive Officer	373k	N/A	1972
Mr. Andreas Holm Mattsson	Co-Founder and Chief AI & Culture Officer	246k	N/A	1976
Mr. Jesper Nyegaard Nissen M.Sc.	Interim CFO & COO	296k	N/A	1970
Dr. Niels Iversen Moeller M.D.	Co-Founder, VP of Business & Director	120k	N/A	1979
Dr. Birgitte Rono Ph.D.	Chief Scientific Officer	336k	N/A	1977
Dr. Jürgen Langhärig EMBA, Ph.D.	Head of Business Development & Member of Advisory Board	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase 1/2a trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. Evaxion Biotech A/S was incorporated in 2008 and is based in Horsholm, Denmark.

Corporate governance

Evaxion Biotech A/S’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.